The question now becomes - was it ethical for @NEJM to publish an early case series that was promoted across the world, and was likely responsible for vast numbers of people receiving remdesivir (perhaps inappropriately)https://twitter.com/peripatetical/status/1253425781260251137 …
I would've been more sanguine had it not been published by NEJM as a clinical study and presented as a major important finding, rather than the tentative evidence it really was